Home » Business » Manufacturing
R&D to expand
By Cathy Ding |
October 28, 2010, Thursday
|
Print Edition
Print Edition
NOVARTIS Oncology said it will expand research and development facilities in the Chinese market and accelerate drug approval process to make more products available domestically.
The investment is among the US$1 billion injection in the next five years from Novartis AG to build its third-largest R&D center in the world in the Zhangjiang Hi-Tech Park in Pudong New Area.
The investment is among the US$1 billion injection in the next five years from Novartis AG to build its third-largest R&D center in the world in the Zhangjiang Hi-Tech Park in Pudong New Area.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
